Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Use of Single-Use Bioreactor Systems – V 2.0

Posted on By


Biosimilars: SOP for Use of Single-Use Bioreactor Systems – V 2.0


Standard Operating Procedure for Use of Single-Use Bioreactor Systems in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/100/2025
Supersedes SOP/BS/100/2022
Page No. Page 1 of 13
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the standard procedure for the preparation, operation, and disposal of single-use bioreactor (SUB) systems used in biosimilar manufacturing, ensuring aseptic processing and operational consistency.

2. Scope

This SOP applies to all single-use bioreactors ranging from 50L to 2000L capacity used in upstream processing within the biosimilars facility.

3. Responsibilities

  • Production: Set up, monitor, and dispose of SUB systems per batch requirement.
  • Engineering: Verify equipment integrity, calibrate load cells, and support automation interfaces.
  • QA: Ensure SUB components are qualified and that batch documentation complies with GMP standards.

4. Accountability

The Manufacturing Head is accountable for ensuring proper utilization and documentation of SUB systems as per validated procedures.

5. Procedure

5.1 Receipt and Inspection of SUB Components

  1. Receive pre-sterilized bioreactor bag assemblies with gamma irradiation certification (Annexure-1).
  2. Verify integrity of ports, sensors, weld lines, and bag labeling.
  3. Check irradiation indicator color change and record batch number.

5.2 Assembly and Installation

  1. Install the bag into the SUB vessel and connect sparger, dip tube, pH/DO probes, and sampling lines.
  2. Use aseptic connections (e.g., AseptiQuik) for media, feed, and vent lines.
  3. Secure probes and tighten clamps to prevent leaks or disconnections.

5.3 System Integrity Testing

  1. Conduct leak test by filling bag with 10–20 L sterile air or nitrogen and applying pressure of 0.2 bar.
  2. Monitor for 10 minutes and confirm no pressure drop.
  3. Record test in Annexure-2: SUB Integrity Log.

5.4 Media Charging and Inoculation

  1. Transfer sterile media through aseptic transfer line using peristaltic pump.
  2. Confirm temperature, pH, and DO sensors are calibrated and functional.
  3. Inoculate culture using sterile connections and begin agitation and aeration based on protocol.

5.5 Operation Monitoring

  1. Monitor bioreactor parameters via control system (e.g., DeltaV, BioPAT).
  2. Record agitation speed, pH, DO, VCD, and temperature every 4 hours or as per BMR.
  3. Document all interventions in Annexure-3: Bioreactor Operation Log.

5.6 Harvest and Disposal

  1. Transfer culture broth to harvest tank via sterile connections.
  2. Drain and seal used SUB bag in biohazard bag and place in designated disposal bin.
  3. Sanitize SUB vessel with 70% IPA before storage.

6. Abbreviations

  • SUB: Single-Use Bioreactor
  • BMR: Batch Manufacturing Record
  • IPA: Isopropyl Alcohol
  • QA: Quality Assurance

7. Documents

  1. Gamma Irradiation Certificate – Annexure-1
  2. SUB Integrity Log – Annexure-2
  3. Bioreactor Operation Log – Annexure-3

8. References

  • FDA Guidance for Industry – Single-Use Technology in Biopharmaceutical Manufacturing (2021)
  • ICH Q9 – Quality Risk Management

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Gamma Irradiation Certificate

Bag ID Lot No. Irradiation Date Indicator Color Checked By
SUB-100L-21 GIR-789 01/05/2025 Orange to Red Ajay Verma

Annexure-2: SUB Integrity Log

Date SUB ID Test Pressure (bar) Hold Time Result Performed By
04/05/2025 SUB-200L-35 0.2 10 min Pass Rajesh Kumar

Annexure-3: Bioreactor Operation Log

Time pH DO (%) Temperature (°C) Agitation (rpm) Operator
08:00 7.1 40 37.0 120 Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Included leak test procedure and annexures for irradiation certificate and logs Periodic review and alignment with FDA guidelines
See also  Biosimilars: SOP for Sterile Addition of Feeds and Supplements in Bioreactor Operations - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: BA-BE Studies: SOP for Reinjection of Samples – V 2.0
Next Post: Aerosol: SOP for Setting Up a Risk Management Program for Aerosol Production – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version